All News #Library
Others
Glycomine Announces Encouraging Efficacy Data from Phase 2 Study in PMM2-CDG
04 Mar 2024 //
BUSINESSWIRE
Glycomine Appoints Dr. Rose Marino Chief Medical Officer
12 Oct 2023 //
BUSINESSWIRE
Data from Glycomine’s Ongoing Natural History Study Provides Insight PMM2-CDG
30 Aug 2023 //
BUSINESSWIRE
Glycomine Announces First Dosing in Phase 1 Clinical Study of GLM101
17 Dec 2021 //
BUSINESSWIRE

Market Place
Sourcing Support